project id: TCGA-LUAD; case submitter id: TCGA-62-A46Y; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 70; days to birth: -25905; days to death: 414; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1938; year of death: 2009; age at diagnosis: 25905; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1608; initial weight: 80.0; sample id: dea6de72-0f67-44f8-aea7-28c15adf4e60; sample submitter id: TCGA-62-A46Y-01A; portion id: ec4875fc-4a47-4109-b1e3-2879376f3075; portion submitter id: TCGA-62-A46Y-01A-11; slide id: 769d7702-02b6-4f1f-a061-056f2e51bf9c; slide submitter id: TCGA-62-A46Y-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 4.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; section location: TOP;